Taysha Gene Therapies, Inc. Common Stock (TSHA) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for TSHA. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 201 institutions reported holding TSHA, with 299.1 million shares worth $2.1 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Avoro Capital Advisors | 23,888,888 | $163M | INCREASED |
| RA Capital Management, | 23,555,648 | $160M | UNCHANGED |
| Goldman Sachs | 22,713,118 | $155M | INCREASED |
| BlackRock | 20,691,927 | $141M | INCREASED |
| Vestal Point Capital | 19,415,000 | $132M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Taysha Gene Therapies, Inc. Common Stock on SentiSense.